Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 13, 2017 Filed Sep 15, 2017 20:14 UTC |
MERLO LARRY JDirector · President and CEO
|
Exercise / conversionStock Option · Derivative | 241,150 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-17-027494 · form4.xml · derivative · entry 8 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 241,150 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 20:14 UTC |
MERLO LARRY JDirector · President and CEO
|
SaleCommon Stock | 241,150 | $83.07 | $20,032,330.50 |
DisclosureSEC source: 0001127602-17-027494 · form4.xml · nonDerivative · entry 3 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,254.5612 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sale prices ranging between $82.22 and $83.68 per share. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 20:14 UTC |
MERLO LARRY JDirector · President and CEO
|
Exercise / conversionCommon Stock | 241,150 | $34.96 | $8,430,604.00 |
DisclosureSEC source: 0001127602-17-027494 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,404.5612 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 21:29 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionStock Option · Derivative | 49,174 | $0.00 Strike: $54.53 | $0.00 |
DisclosureSEC source: 0001127602-17-027343 · form4.xml · derivative · entry 9 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49,174 shares Expires 2020-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 21:29 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionStock Option · Derivative | 41,093 | $0.00 Strike: $48.67 | $0.00 |
DisclosureSEC source: 0001127602-17-027343 · form4.xml · derivative · entry 8 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,547 Underlying: Common Stock · 41,093 shares Expires 2022-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 10/1/2015. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 21:29 UTC |
Moriarty Thomas MEVP & General Counsel
|
SaleCommon Stock | 49,174 | $79.61 | $3,914,742.14 |
DisclosureSEC source: 0001127602-17-027343 · form4.xml · nonDerivative · entry 4 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,009.1134 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.38 and $80.00 per share. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 21:29 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionCommon Stock | 49,174 | $54.53 | $2,681,458.22 |
DisclosureSEC source: 0001127602-17-027343 · form4.xml · nonDerivative · entry 3 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,183.1134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 21:29 UTC |
Moriarty Thomas MEVP & General Counsel
|
SaleCommon Stock | 41,093 | $79.61 | $3,271,413.73 |
DisclosureSEC source: 0001127602-17-027343 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,009.1134 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.33 and $80.00 per share. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 21:29 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionCommon Stock | 41,093 | $48.67 | $1,999,996.31 |
DisclosureSEC source: 0001127602-17-027343 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,102.1134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 21:33 UTC |
Denton David MEVP and CFO
|
Exercise / conversionStock Option · Derivative | 108,183 | $0.00 Strike: $54.53 | $0.00 |
DisclosureSEC source: 0001127602-17-027344 · form4.xml · derivative · entry 7 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 108,183 shares Expires 2020-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 21:33 UTC |
Denton David MEVP and CFO
|
SaleCommon Stock | 108,183 | $79.62 | $8,613,530.46 |
DisclosureSEC source: 0001127602-17-027344 · form4.xml · nonDerivative · entry 4 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,056.399 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F4 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.33 and $80.00 per share. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 21:33 UTC |
Denton David MEVP and CFO
|
Exercise / conversionCommon Stock | 108,183 | $54.53 | $5,899,218.99 |
DisclosureSEC source: 0001127602-17-027344 · form4.xml · nonDerivative · entry 3 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,239.399 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 21:33 UTC |
Denton David MEVP and CFO
|
SaleCommon Stock | 105,040 | $79.68 | $8,369,587.20 |
DisclosureSEC source: 0001127602-17-027344 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,056.399 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.35 and $80.00 per share. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 21:33 UTC |
Denton David MEVP and CFO
|
SaleCommon Stock | 23,855 | $79.61 | $1,899,096.55 |
DisclosureSEC source: 0001127602-17-027344 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,096.399 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.33 and $80.00 per share. Read SEC document |
| August 23, 2017 Filed Sep 15, 2017 20:14 UTC |
MERLO LARRY JDirector · President and CEO
|
GiftCommon Stock | 14,163 | $77.61 | $1,099,190.43 |
DisclosureSEC source: 0001127602-17-027494 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,254.5612 Read SEC document |
| August 16, 2017 Filed Aug 18, 2017 20:10 UTC |
SWIFT RICHARD JDirector
|
SaleCommon Stock | 2,500 | $79.62 | $199,050.00 |
DisclosureSEC source: 0001127602-17-026036 · form4.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,258 F1 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $79.54 and $79.66 per share. Read SEC document |
| June 26, 2017 Filed Jun 28, 2017 20:51 UTC |
Foulkes HelenaEVP, President-CVS Pharmacy
|
Exercise / conversionStock Option · Derivative | 6,029 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-17-022294 · form4.xml · derivative · entry 8 Foulkes Helena · CIK 0001429996 · EVP, President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,029 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| June 26, 2017 Filed Jun 28, 2017 20:51 UTC |
Foulkes HelenaEVP, President-CVS Pharmacy
|
Exercise / conversionStock Option · Derivative | 14,304 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-17-022294 · form4.xml · derivative · entry 7 Foulkes Helena · CIK 0001429996 · EVP, President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,304 shares Expires 2021-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2014. Read SEC document |
| June 26, 2017 Filed Jun 28, 2017 20:51 UTC |
Foulkes HelenaEVP, President-CVS Pharmacy
|
SaleCommon Stock | 20,333 | $80.00 | $1,626,640.00 |
DisclosureSEC source: 0001127602-17-022294 · form4.xml · nonDerivative · entry 3 Foulkes Helena · CIK 0001429996 · EVP, President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,996.6533 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $80.00 and $80.02 per share. Read SEC document |
| June 26, 2017 Filed Jun 28, 2017 20:51 UTC |
Foulkes HelenaEVP, President-CVS Pharmacy
|
Exercise / conversionCommon Stock | 6,029 | $34.96 | $210,773.84 |
DisclosureSEC source: 0001127602-17-022294 · form4.xml · nonDerivative · entry 2 Foulkes Helena · CIK 0001429996 · EVP, President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,329.6533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 26, 2017 Filed Jun 28, 2017 20:51 UTC |
Foulkes HelenaEVP, President-CVS Pharmacy
|
Exercise / conversionCommon Stock | 14,304 | $34.96 | $500,067.84 |
DisclosureSEC source: 0001127602-17-022294 · form4.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · EVP, President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,300.6533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:56 UTC |
Foulkes HelenaEVP, President-CVS Pharmacy
|
Exercise / conversionStock Option · Derivative | 6,029 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-17-022005 · form4.xml · derivative · entry 8 Foulkes Helena · CIK 0001429996 · EVP, President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,029 Underlying: Common Stock · 6,029 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:56 UTC |
Foulkes HelenaEVP, President-CVS Pharmacy
|
Exercise / conversionStock Option · Derivative | 14,303 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-17-022005 · form4.xml · derivative · entry 7 Foulkes Helena · CIK 0001429996 · EVP, President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,304 Underlying: Common Stock · 14,303 shares Expires 2021-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2014. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:56 UTC |
Foulkes HelenaEVP, President-CVS Pharmacy
|
SaleCommon Stock | 20,332 | $76.98 | $1,565,157.36 |
DisclosureSEC source: 0001127602-17-022005 · form4.xml · nonDerivative · entry 3 Foulkes Helena · CIK 0001429996 · EVP, President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,996.6533 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $76.58 and $77.39 per share. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:56 UTC |
Foulkes HelenaEVP, President-CVS Pharmacy
|
Exercise / conversionCommon Stock | 6,029 | $34.96 | $210,773.84 |
DisclosureSEC source: 0001127602-17-022005 · form4.xml · nonDerivative · entry 2 Foulkes Helena · CIK 0001429996 · EVP, President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,328.6533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:56 UTC |
Foulkes HelenaEVP, President-CVS Pharmacy
|
Exercise / conversionCommon Stock | 14,303 | $34.96 | $500,032.88 |
DisclosureSEC source: 0001127602-17-022005 · form4.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · EVP, President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,299.6533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 20:22 UTC |
Denton David MEVP and CFO
|
Exercise / conversionStock Option · Derivative | 107,178 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-17-021306 · form4.xml · derivative · entry 9 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 107,178 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 20:22 UTC |
Denton David MEVP and CFO
|
Exercise / conversionStock Option · Derivative | 110,912 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-17-021306 · form4.xml · derivative · entry 8 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 110,912 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 20:22 UTC |
Denton David MEVP and CFO
|
Exercise / conversionStock Option · Derivative | 12,420 | $0.00 Strike: $40.28 | $0.00 |
DisclosureSEC source: 0001127602-17-021306 · form4.xml · derivative · entry 7 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,420 shares Expires 2018-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 3/5/2011. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 20:22 UTC |
Denton David MEVP and CFO
|
SaleCommon Stock | 230,510 | $80.00 | $18,440,800.00 |
DisclosureSEC source: 0001127602-17-021306 · form4.xml · nonDerivative · entry 4 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,562.8314 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 20:22 UTC |
Denton David MEVP and CFO
|
Exercise / conversionCommon Stock | 107,178 | $34.96 | $3,746,942.88 |
DisclosureSEC source: 0001127602-17-021306 · form4.xml · nonDerivative · entry 3 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,072.8314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 20:22 UTC |
Denton David MEVP and CFO
|
Exercise / conversionCommon Stock | 110,912 | $45.07 | $4,998,803.84 |
DisclosureSEC source: 0001127602-17-021306 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,894.8314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 20:22 UTC |
Denton David MEVP and CFO
|
Exercise / conversionCommon Stock | 12,420 | $40.28 | $500,277.60 |
DisclosureSEC source: 0001127602-17-021306 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,982.8314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2017 Filed May 12, 2017 20:53 UTC |
SCHAPIRO MARY LDirector
|
GrantShare Credits · Derivative | 1,729.6763 | $80.94 Strike: $0.00 | $140,000.00 |
DisclosureSEC source: 0001127602-17-017939 · form4.xml · derivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,729.6763 Underlying: Common Stock · 1,729.6763 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 10, 2017 Filed May 12, 2017 21:00 UTC |
DORMAN DAVID WDirector
|
GrantCommon Stock | 3,521 | $80.94 | $284,989.74 |
DisclosureSEC source: 0001127602-17-017941 · form4.xml · nonDerivative · entry 1 DORMAN DAVID W · CIK 0001082870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,207 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 10, 2017 Filed May 12, 2017 21:04 UTC |
DEPARLE NANCY ANNDirector
|
GrantCommon Stock | 1,297 | $80.94 | $104,979.18 |
DisclosureSEC source: 0001127602-17-017942 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,892 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 10, 2017 Filed May 12, 2017 21:05 UTC |
BRACKEN RICHARD MDirector
|
GrantCommon Stock | 1,389 | $80.94 | $112,425.66 |
DisclosureSEC source: 0001127602-17-017943 · form4.xml · nonDerivative · entry 1 BRACKEN RICHARD M · CIK 0001216830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,633 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 10, 2017 Filed May 12, 2017 21:07 UTC |
MILLON JEAN PIERREDirector
|
GrantCommon Stock | 1,297 | $80.94 | $104,979.18 |
DisclosureSEC source: 0001127602-17-017947 · form4.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,297 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 10, 2017 Filed May 12, 2017 21:09 UTC |
WHITE TONY LDirector
|
GrantCommon Stock | 1,297 | $80.94 | $104,979.18 |
DisclosureSEC source: 0001127602-17-017948 · form4.xml · nonDerivative · entry 1 WHITE TONY L · CIK 0001171315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,999 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 10, 2017 Filed May 12, 2017 21:11 UTC |
BROWN C DAVID IIDirector
|
GrantShare Credits · Derivative | 1,853.2246 | $80.94 Strike: $0.00 | $150,000.00 |
DisclosureSEC source: 0001127602-17-017949 · form4.xml · derivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,400.9027 Underlying: Common Stock · 1,853.2246 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 10, 2017 Filed May 12, 2017 21:13 UTC |
DECOUDREAUX ALECIA ADirector
|
GrantShare Credits · Derivative | 1,729.6763 | $80.94 Strike: $0.00 | $140,000.00 |
DisclosureSEC source: 0001127602-17-017951 · form4.xml · derivative · entry 1 DECOUDREAUX ALECIA A · CIK 0001233354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,221.2055 Underlying: Common Stock · 1,729.6763 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 10, 2017 Filed May 12, 2017 21:15 UTC |
SWIFT RICHARD JDirector
|
GrantShare Credits · Derivative | 1,413.0838 | $80.94 Strike: $0.00 | $114,375.00 |
DisclosureSEC source: 0001127602-17-017952 · form4.xml · derivative · entry 2 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,012.5537 Underlying: Common Stock · 1,413.0838 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 10, 2017 Filed May 12, 2017 21:17 UTC |
WELDON WILLIAM CDirector
|
GrantShare Credits · Derivative | 1,729.6763 | $80.94 Strike: $0.00 | $140,000.00 |
DisclosureSEC source: 0001127602-17-017955 · form4.xml · derivative · entry 2 WELDON WILLIAM C · CIK 0001189019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,799.5882 Underlying: Common Stock · 1,729.6763 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 10, 2017 Filed May 12, 2017 21:19 UTC |
Finucane Anne A.Director
|
GrantShare Credits · Derivative | 1,297.2572 | $80.94 Strike: $0.00 | $105,000.00 |
DisclosureSEC source: 0001127602-17-017957 · form4.xml · derivative · entry 3 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,009.4012 Underlying: Common Stock · 1,297.2572 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:31 UTC |
MERLO LARRY JDirector · President and CEO
|
GrantStock Option · Derivative | 338,105 | $78.05 Strike: $78.05 | $26,389,095.25 |
DisclosureSEC source: 0001127602-17-014045 · form4.xml · derivative · entry 7 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,105 Underlying: Common Stock · 338,105 shares Expires 2024-04-03 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:31 UTC |
MERLO LARRY JDirector · President and CEO
|
GrantCommon Stock (restricted) | 43,241 | $78.05 | $3,374,960.05 |
DisclosureSEC source: 0001127602-17-014045 · form4.xml · nonDerivative · entry 3 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,116 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:32 UTC |
Roberts Jonathan CEVP & Chief Operating Officer
|
GrantStock Option · Derivative | 200,358 | $78.05 Strike: $78.05 | $15,637,941.90 |
DisclosureSEC source: 0001127602-17-014046 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,358 Underlying: Common Stock · 200,358 shares Expires 2024-04-03 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:32 UTC |
Roberts Jonathan CEVP & Chief Operating Officer
|
GrantCommon Stock (restricted) | 25,624 | $78.05 | $1,999,953.20 |
DisclosureSEC source: 0001127602-17-014046 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,780 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:37 UTC |
Moriarty Thomas MEVP & General Counsel
|
GrantStock Option · Derivative | 125,224 | $78.05 Strike: $78.05 | $9,773,733.20 |
DisclosureSEC source: 0001127602-17-014055 · form4.xml · derivative · entry 5 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,224 Underlying: Common Stock · 125,224 shares Expires 2024-04-03 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:37 UTC |
Moriarty Thomas MEVP & General Counsel
|
GrantCommon Stock (restricted) | 16,015 | $78.05 | $1,249,970.75 |
DisclosureSEC source: 0001127602-17-014055 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,668 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.